Julian Bertschinger

Julian Bertschinger is co-founder and CEO of Covagen. From 2007 until 2014, he raised CHF 58.9 million of venture capital, entered a strategic collaboration and licensing agreement with Mitsubishi Tanabe Pharma with a total deal value of EUR 220 million, and advanced Covagen’s lead asset to Phase I/II a clinical trials. In August 2014, Covagen